Condition: Colorectal Neoplasms · Colorectal Adenoma · Colorectal Cancer · Sponsor: Chinese University of Hong Kong
This multicenter, double blinded randomized controlled trial aims to assess the efficacy of a novel oral synbiotic formula (SMT04) in reducing advanced adenoma recurrence and colorectal neoplasia-related bacterial gene markers after endoscopic resection of colorectal advanced neoplasia.
This description comes directly from the study's public registry record.
Louis Lau · 35052211 · louishslau@cuhk.edu.lhk
Always discuss trial participation with your own doctor first.
| Inner Mongolia People's Hospital | Hohhot, Inner Mongolia, China | Not Yet Recruiting |
| Prince of Wales Hospital | Hong Kong, Hong Kong | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05592886